Pfizer Profit & Loss Annual

BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | Sector: Major Drugs

5,241.00 +18.95 (0.36%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	2,193.17	2,424.76	2,610.99	2,238.55
Total Revenue	2,193.17	2,424.76	2,610.99	2,238.55
Costof Revenue Total	792.57	927.65	1,008.68	858.73
Gross Profit	1,400.60	1,497.11	1,602.31	1,379.82
Selling/ General/ Admin Expenses Total	347.80	650.55	740.31	633.05
Depreciation/ Amortization	62.28	104.02	113.61	108.02
Unusual Expense( Income)	-7.95	-33.46	-3.00	-4.22
Other Operating Expenses Total	417.50	30.07	18.38	28.26
Total Operating Expense	1,612.20	1,680.32	1,879.37	1,625.23
Operating Income	580.97	744.44	731.62	613.32
Interest Inc( Exp) Net- Non- Op Total	-154.10	715.00	373.40	275.50
Other Net	180.51	8.02	2.35	27.77
Net Income Before Taxes	746.07	824.01	772.89	668.72
Provisionfor Income Taxes	194.74	200.08	160.33	171.11
Net Income After Taxes	551.33	623.93	612.56	497.61
Net Income Before Extra Items	551.33	623.93	612.56	497.61
Net Income	551.33	623.93	612.56	497.61
Income Availableto Com Excl Extra Ord	551.33	623.93	612.56	497.61
Income Availableto Com Incl Extra Ord	551.33	623.93	612.56	497.61
Diluted Net Income	551.33	623.93	612.56	497.61
Diluted Weighted Average Shares	4.62	4.58	4.58	4.58
Diluted EPS Excluding Extra Ord Items	119.22	136.38	133.89	108.77
DPS- Common Stock Primary Issue	35.00	35.00	35.00	30.00
Diluted Normalized EPS	117.95	130.83	133.10	108.07
Interest Exp( Inc) Net- Operating Total	-	14.90	13.90	13.90
Gain( Loss)on Saleof Assets	-	0.50	15.80	0.80